Global Liposome Drug Delivery market will reach 5190 million US$ by the end of 2025

Global Liposome Drug Delivery market will reach 5190 million US$ by the end of 2025 QYRESEARCH FOCUS ON MARKET SURVEY AND RESEARCH

www.qyresearch.com

CONTACT

Beijing Hengzhou Bozhi International Information Consulting Web: www.qyresearch.com TEL:+86-13660489419, Office:+86-2022093278 Media: press@qyresearch.com

Marketing: sales@qyresearchglobal.com Facebook: @QYResearchOfficial Twitter: @QYResearch_ Wechat Official Account: QYResearch, Weibo: 恒州博智

QYResearch • Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.

• In consideration of the global economic and pharma industry, the growth rate of Liposomes Drug Delivery market will keep high in the next several years. The revenue market size expected to be 3.6 billion USD in 2020 at a CAGR of 8.57%.

QYR

• North America dominated the market with market share of 44.2% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12.85%.

QYR

• Liposomes have been used in a broad range of pharmaceutical applications. Liposomes are showing particular promise as intracellular delivery systems for antisense molecules, ribosomes, proteins/peptides, and DNA. Liposomes with enhanced drug delivery to disease locations, by ability of long circulation residence times, are now achieving clinical acceptance. Also, liposomes promote targeting of particular diseased cells within the disease site.

QYR

• Finally, liposomal drugs exhibit reduced toxicities and retain enhanced efficacy compared with free complements.

Based on the pharmaceutical applications and available products, we can say that liposomes have definitely established their position in modern delivery systems.

QYR

The global Liposome Drug Delivery (Liposomes Drug Delivery) market is valued at 2400 million US$ in 2017 and will reach 5190 million US$ by the end of 2025, growing at a CAGR of 10.1% during 2018-2025.

Click to view the full report: https://www.qyresearch.com/index/detail/542058/globalliposome-drug-delivery-liposomes-drug-delivery-market